Paclitaxel is an effective chemotherapeutic agent for many cancers, but it has a number of limiting side effects that not only significantly reduce the quality of life of patients, but also limit their further treatment. Peripheral neuropathy is one of these, but there are currently no proven effective druHS for the prevention or treatment of paclitaxel-induced neuropathic pain (PINP) in particular, or chemotherapy-induced peripheral neuropathy (CIPN) in general. 2-ethyl-6-methyl-3-hydroxypyridine succinate (HS) is a derivative of succinic acid with neuroprotective, antihypoxic, membrane-protective, nootropic, sedative effects. The aim of the study was to study the effect of the neuroprotective agent HS on the pathomorphogenesis of the sci...
Chemotherapy-Induced Peripheral Neuropathy (CIPN) is a major dose-limiting side effect of several an...
Chemotherapy-induced peripheral neuropathy (CIPN) is a type of neuropathic pain that represents a fr...
By 2030, 4 million people are estimated to survive cancer in the UK. Increased survival rates are th...
Paclitaxel is an effective chemotherapeutic agent for many cancers, but it has a number of limiting ...
Paclitaxel is an essential drug in the chemotherapy of ovarian, non-small cell lung, breast, gastric...
Paclitaxel (Brand name Taxol) is widely used in the treatment of common cancers like breast, ovarian...
IntroductionChemotherapy-induced peripheral neuropathy (CIPN) is a common consequence of cancer trea...
Chemotherapy induced peripheral neuropathy (CIPN) is a debilitating condition that affects up to 70%...
[[abstract]]Chemotherapy-induced neurotoxicity is a common adverse effect of cancer treatment. No me...
[[abstract]]Chemotherapy-induced neurotoxicity is a common adverse effect of cancer treatment. No me...
Chemotherapy-induced peripheral neuropathy (CIPN) is a common dose-limiting side effect of multiple ...
Despite the large amount of human and experimental studies no effective (prophylactic) treatment exi...
Chemotherapy-induced peripheral neuropathy (CIPN) is a type of neuropathic pain that represents a fr...
Chemotherapy-induced peripheral neuropathy (CIPN) is a debilitating and dose-limiting side effect of...
Peripheral neuropathy is a common side effect of paclitaxel. Clinical studies suggest that different...
Chemotherapy-Induced Peripheral Neuropathy (CIPN) is a major dose-limiting side effect of several an...
Chemotherapy-induced peripheral neuropathy (CIPN) is a type of neuropathic pain that represents a fr...
By 2030, 4 million people are estimated to survive cancer in the UK. Increased survival rates are th...
Paclitaxel is an effective chemotherapeutic agent for many cancers, but it has a number of limiting ...
Paclitaxel is an essential drug in the chemotherapy of ovarian, non-small cell lung, breast, gastric...
Paclitaxel (Brand name Taxol) is widely used in the treatment of common cancers like breast, ovarian...
IntroductionChemotherapy-induced peripheral neuropathy (CIPN) is a common consequence of cancer trea...
Chemotherapy induced peripheral neuropathy (CIPN) is a debilitating condition that affects up to 70%...
[[abstract]]Chemotherapy-induced neurotoxicity is a common adverse effect of cancer treatment. No me...
[[abstract]]Chemotherapy-induced neurotoxicity is a common adverse effect of cancer treatment. No me...
Chemotherapy-induced peripheral neuropathy (CIPN) is a common dose-limiting side effect of multiple ...
Despite the large amount of human and experimental studies no effective (prophylactic) treatment exi...
Chemotherapy-induced peripheral neuropathy (CIPN) is a type of neuropathic pain that represents a fr...
Chemotherapy-induced peripheral neuropathy (CIPN) is a debilitating and dose-limiting side effect of...
Peripheral neuropathy is a common side effect of paclitaxel. Clinical studies suggest that different...
Chemotherapy-Induced Peripheral Neuropathy (CIPN) is a major dose-limiting side effect of several an...
Chemotherapy-induced peripheral neuropathy (CIPN) is a type of neuropathic pain that represents a fr...
By 2030, 4 million people are estimated to survive cancer in the UK. Increased survival rates are th...